EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Engineering copper homeostasis for microenvironment-adaptive therapy in inflammation-driven disorders

Feixiang Ding, Junyan Liu, Min Liu, Hong Huang, Huifang Tang, Jun Zhong, Chong Liu, Zhaoqian Liu

Bioactive Materials · 2027-04 · 70 · 83-120

DOI: 10.1016/j.bioactmat.2026.09.047 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioactive Materials, 2027-04. Verfasst von Feixiang Ding und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, National Clinical Research Center for Geriatric Disorders, Xiangya Hos…. Die Arbeit nennt 557 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Major Science and Technology Projects of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation-driven disorders (IDDs) arise from distinct initiating events, yet many persist because immune activation, oxidative and metabolic stress, regulated cell death, and tissue remodeling form self-reinforcing local niches. Copper connects these processes through its roles as a cuproenzyme cofactor, redox-active species and dynamically trafficked regulatory metal. Its therapeutic significance, however, is determined by disease stage, cell type, subcellular distribution and chemical state. Copper deficiency, excess or mislocalization may therefore be adaptive, protective or pathogenic in different contexts. This review develops a disease- and copper-state-specific framework that links copper homeostasis to therapeutic platform design. We first examine inflammation-associated remodeling of copper trafficking and compare representative copper states in autoimmune joint disease, metabolic inflammation, fibrosis, inflammation-associated cancer and infection-associated tissue repair. We then critically evaluate copper-dependent and copper-sensitive mechanisms governing inflammatory mediator availability, immune-cell programming and checkpoint regulation, regulated cell death, angiogenesis and stromal remodeling, while distinguishing direct mechanistic evidence from model-dependent inference. Building on this analysis, we compare pharmacological modulators with nanocarriers, copper-containing active materials and local copper-sequestering platforms that implement copper chelation or sequestration, controlled copper delivery or release, intracellular redistribution, and catalytic activation or nanozyme-like redox regulation. We further outline how pathological copper pools, activation cues, release kinetics, speciation, biodistribution and target engagement should be measured so that precision is demonstrated rather than inferred from material composition. This framework positions copper modulation as a context-specific complement to existing therapy and defines the mechanistic, analytical and translational evidence required for microenvironment-adaptive treatment of IDDs.

Schlagwörter

Stichwörter der Autor:innen

Copper homeostasisCopper traffickingCopper-modulating biomaterialsInflammation-driven disordersMicroenvironment-adaptive therapy

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, PR China.
  • Department of Lymphoma and Hematology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha 410003, P. R. China.
  • Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, PR China.
  • Department of Orthopedics, The Third Xiangya Hospital, Central South University, 410013, PR China.
  • Department of Cardiology, Hunan Provincial Key Laboratory of Multi-omics and Artificial Intelligence of Cardiovascular Diseases, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyan…

Förderung

  • National Major Science and Technology Projects of China

Zitieren

APA

Ding, F., Liu, J., Liu, M., Huang, H., Tang, H., Zhong, J., Liu, C., & Liu, Z. (2027). Engineering copper homeostasis for microenvironment-adaptive therapy in inflammation-driven disorders. Bioactive Materials, 70, 83-120. https://doi.org/10.1016/j.bioactmat.2026.09.047

Vancouver

Ding F, Liu J, Liu M, Huang H, Tang H, Zhong J, et al. Engineering copper homeostasis for microenvironment-adaptive therapy in inflammation-driven disorders. Bioactive Materials. 2027;70:83-120. doi:10.1016/j.bioactmat.2026.09.047

BibTeX
@article{Ding2027,
  author = {Ding, Feixiang and Liu, Junyan and Liu, Min and Huang, Hong and Tang, Huifang and Zhong, Jun and Liu, Chong and Liu, Zhaoqian},
  title = {Engineering copper homeostasis for microenvironment-adaptive therapy in inflammation-driven disorders},
  journal = {Bioactive Materials},
  year = {2027},
  volume = {70},
  pages = {83--120},
  doi = {10.1016/j.bioactmat.2026.09.047}
}
Kostenlos starten →